AR and prostate cancer: In this study, we demonstrated the inhibitory effects of Remodelin on AR-positive and AR-negative PCas, revealing that NAT10 is involved in DNA replication, possibly through its interaction with CDC6 and AR, and we further clarified that Remodelin retains the ability to inhibit the growth of castration-resistant prostate cancer cells in vitro.